贝叶斯预测概率基于单臂II期研究的双变指数向量,具有二进制效率和安全性终点
Takuya Yoshimoto1,2, Satoru Shinoda2, Kouji Yamamoto2
1Biometrics Department, Chugai Pharmaceutical Co. Ltd, Chuo-ku, Tokyo, Japan.
Pharmaceutical statistics
|August 14, 2024
概括
这项研究引入了一种新的贝叶斯监测策略,用于瘤学II期试验. 该方法使用一个索引向量来改善推进癌症药物候选者的临时去/不去决策.
科学领域:
- 临床试验 临床试验
- 在瘤学瘤学.
- 生物统计学 生物统计学
背景情况:
- 二期瘤学研究对于推进潜在的癌症治疗非常重要.
- 传统的II期试验重点是疗效,但药物安全性也是至关重要的.
- 现有的贝叶斯监测策略评估基于预测概率的试验延续.
研究的目的:
- 提出一个新的索引向量来总结二期试验结果.
- 加强临床试验开发中的临时去/不去决策.
- 解决现有策略在捕获多个试验结果方面的局限性.
主要方法:
- 开发一个简单的索引向量来定义最糟糕和最有前途的治疗效果场景.
- 使用索引向量来测量这些定义的场景之间的偏差.
- 进行模拟研究以评估拟议方法的操作特性.
主要成果:
- 拟议的索引向量有效地总结了关键试验结果.
- 模拟研究证实了该方法能够做出适当的临时决定的能力.
- 新战略加强了对III期试验进展的证据评估.
结论:
- 新型索引向量为贝叶斯监测在II期瘤学试验中的宝贵工具.
- 这种方法提高了癌症药物开发的去/不去决策的可靠性.
- 与现有策略相比,该方法提供了更全面的试验结果总结.
更多相关视频
09:35A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
Published on: August 16, 2017
17.8K
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
1.8K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Actuarial Approach
69
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
69
Hazard Ratio
103
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
103
Binomial Probability Distribution
10.3K
A binomial distribution is a probability distribution for a procedure with a fixed number of trials, where each trial can have only two outcomes.
The outcomes of a binomial experiment fit a binomial probability distribution. A statistical experiment can be classified as a binomial experiment if the following conditions are met:
There are a fixed number of trials. Think of trials as repetitions of an experiment. The letter n denotes the number of trials.
There are only two possible outcomes,...
The outcomes of a binomial experiment fit a binomial probability distribution. A statistical experiment can be classified as a binomial experiment if the following conditions are met:
There are a fixed number of trials. Think of trials as repetitions of an experiment. The letter n denotes the number of trials.
There are only two possible outcomes,...
10.3K
Kaplan-Meier Approach
115
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
115
Odds Ratio
115
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
115
